These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18239843)

  • 1. Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis.
    Richy F; Dukas L; Schacht E
    Calcif Tissue Int; 2008 Feb; 82(2):102-7. PubMed ID: 18239843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The D-hormone analog alfacalcidol: the pioneer beyond the horizon of osteoporosis treatment.
    Orimo H; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():4-10. PubMed ID: 16142845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Vitamin D on falls: a meta-analysis.
    Bischoff-Ferrari HA; Dawson-Hughes B; Willett WC; Staehelin HB; Bazemore MG; Zee RY; Wong JB
    JAMA; 2004 Apr; 291(16):1999-2006. PubMed ID: 15113819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
    Schacht E; Richy F; Reginster JY
    J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of alfacalcidol for reducing increased risk of falls and fractures.
    Ringe JD; Schacht E
    Rheumatol Int; 2009 Aug; 29(10):1177-85. PubMed ID: 19159932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls.
    O'Donnell S; Moher D; Thomas K; Hanley DA; Cranney A
    J Bone Miner Metab; 2008; 26(6):531-42. PubMed ID: 18979152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.
    Schacht E; Dukas L; Richy F
    J Musculoskelet Neuronal Interact; 2007; 7(2):174-84. PubMed ID: 17627088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S; Wazny LD; Martin JE
    Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for active vitamin D and analogs in the treatment of osteoporosis.
    Nishii Y
    J Cell Biochem; 2003 Feb; 88(2):381-6. PubMed ID: 12520540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low creatinine clearance, glucocorticoid treatment, rheumatoid arthritis--different etiologies for low D-hormone syndrome and its associated increased risk for falls.
    Dukas LC; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():44-6. PubMed ID: 16142851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alfacalcidol versus plain vitamin D in inflammation induced bone loss.
    Scharla SH; Schacht E; Lempert UG
    J Rheumatol Suppl; 2005 Sep; 76():26-32. PubMed ID: 16142848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in overlapping meta-analyses of vitamin D supplements and falls.
    Bolland MJ; Grey A; Reid IR
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4265-72. PubMed ID: 25093621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of vitamin D in the treatment of osteoporosis in the elderly].
    Pfeifer M; Minne HW
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():15-9. PubMed ID: 16826364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol.
    Ringe JD; Schacht E
    Rheumatol Int; 2007 Dec; 28(2):103-11. PubMed ID: 17668216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of calcitriol on falls and fractures and physical performance tests.
    Gallagher JC
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):497-501. PubMed ID: 15225827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy for prevention of falls and fractures].
    Ringe JD
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():1-5. PubMed ID: 16826362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.